DCAF1 and meningioma: We used the neddylation inhibitor MLN3651, which is structurally distinct from the first-in-class neddylation inhibitor pevonedistat, to decrease the E3 ligase activity of CRLs, including CRL4-DCAF1, in primary meningioma cells.